RxDoctor Payments Data

Daniel Weiland, MD

Sports Medicine · Fairfield, CTNPI 1821027244

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Depuy Synthes Products, Inc. at 51.2% of the total. Reporting peaked in 2022 at $4,490 and has fallen 87.1% since, to $581 in 2025.

$7,115in general payments, 2019–2025

Across 44 payments — averaging $161.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Depuy Synthes Products, Inc.$4K
  • Johnson & Johnson$1K
  • Stryker$918
  • Linvatec Corporation$295
  • Smith+Nephew$279
  • Polaris Technology Solutions LLC$258
  • plus $278 from 4 others
$9,660in research payments, 2019–2025

Across 1 payment — averaging $9660.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medical Device Business Services, Inc.$10K

What the payments were for

  • Consulting fees$3,64051%
  • Travel & lodging$6649%
  • Food & beverage$2,81140%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,115 in reported general payments places this provider in the 65th percentile of 65 sports medicine providers in Connecticut.

See all sports medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$92,447
Medicare patients
213
Services billed
1,135

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam34$53

Paid to pharmacies, not to this prescriber.

Other sports medicine in Fairfield

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →